Menu

Podcast: Innovating to Meet Reproductive Health Needs with Multipurpose Prevention Technologies

On this episode of “One World, One Health” podcast, Dr. Bethany Young Holt of PHI’s CAMI Health discusses Multipurpose Prevention Technologies (MPTs)—products that combine contraceptives with sexually transmitted infection (STI) prevention.

Do women get STIs as often as men? Why do women need MPTs? Aren’t condoms enough? What do these technologies look like?

On this episode of the “One World, One Health” podcast, Dr. Bethany Young Holt of PHI’s CAMI Health discusses Multipurpose Prevention Technologies (MPTs)—products that provide not just contraception, but protection against HIV and other sexually transmitted infections for people around the world.

MPT podcast

Multipurpose Prevention Technologies — Innovating to Meet Women's Needs

Dr. Bethany Young Holt is the Founder and Director of PHI's CAMI Health, an organization dedicated to advancing the health of women and girls worldwide. She is also the Co-Founder and Director of the Initiative for MPTs (IMPT), and a Principal Investigator (PI) at the Public Health Institute. She is a lecturer in the Department of Public Health at California State University, Sacramento. She has over 25 years of experience working on health prevention programs and research projects in the United States, Africa, and South Pacific. Bethany holds a PhD in Epidemiology, an MPH in Maternal and Child Health from University of California, Berkeley, and a BS in Biology from the College of Wooster.

Listen Here

When you empower women to protect themselves around their health—when and if they want to have children—that improves not only the woman’s life, but the economic well-being of her family and the whole community. So when women are protecting themselves from HIV and unintended pregnancy, they’re protecting their children that are living and the ones that are to come. Dr. Bethany Young Holt

Founder & Director, PHI’s CAMI Health


Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org